Article
2,3,7,8-tetrachlorodibenzo-p-dioxin slows the progression of experimental cutaneous Leishmaniasis in susceptible BALB/c and SCID mice.
PloS one - 1 Jan 2013
DeKrey Gregory K, Teagarden Riane E, Lenberg Jerica L, Titus Richard G
Abstract excerpt
In a model of experimental cutaneous leishmaniasis, pre-exposure of Leishmania major-resistant mice to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), an aryl hydrocarbon receptor agonist, causes suppression of the protective anti-parasite T helper 1 response while paradoxically also reducing parasite burdens in those animals. In this study, we examined if TCDD exposure could also reduce parasite burdens in L....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
